Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.076 | 0.7 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |